Smoking Cessation in Groups and With Tobacco Pastils
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00265460 |
Recruitment Status
:
Completed
First Posted
: December 14, 2005
Last Update Posted
: September 15, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Smoking | Drug: Oliwer Twist smokeless tobacco (tobacco) | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 240 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Phase 2 Study of Smoke Free Tobacco and Group Support for Smoking Cessation |
Study Start Date : | March 2005 |
Actual Study Completion Date : | November 2006 |
- Continuous Smoking cessation quit rate after 6 and 12 months
- Side effects from tested tobacco product
- Intake of nicotine and thiocyanate

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 25 Years to 70 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- smoking > 13 cigarettes/day
- healthy (allowed: hypertension, diabetes type 2, mild asthma/COPD, hypercholesterolemia)
- motivated for cessation
- motivated to use tobacco pastils
- motivated for group support
Exclusion Criteria:
- severe diseases
- psychiatric diseases
- using antipsychotic drugs
- used NRT/bupropion in the last 3 months
- consuming > 6 drinks/day
- pregnant/lactating
- stopped smoking more than 2 days during last 3 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00265460
Denmark | |
Dept. pulmonary medicine Y, Gentofte University Hospital | |
Copenhagen, Hellerup, Denmark, 2900 |
Study Chair: | Philip Tønnesen, M.D., Ph.D. | Chair dept. pulm. medicine, Gentofte Hospital |
Publications of Results:
ClinicalTrials.gov Identifier: | NCT00265460 History of Changes |
Other Study ID Numbers: |
Tonga.2005.00. |
First Posted: | December 14, 2005 Key Record Dates |
Last Update Posted: | September 15, 2009 |
Last Verified: | September 2009 |
Keywords provided by University Hospital, Gentofte, Copenhagen:
smoking cessation, nicotine, smokeless tobacco, cigarettes |
Additional relevant MeSH terms:
Lobeline Ganglionic Stimulants Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Nicotinic Agonists |
Cholinergic Agonists Cholinergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Respiratory System Agents |